Bioverge Funds, Excision Bio I, LLC — Form D
Bioverge Funds, Excision Bio I, LLC of BOISE, ID, a pooled investment fund, filed a Form D exempt-offering notice with the SEC on 2020-03-16. The offering totals $150K, of which $142K was reported sold. Industry: Investing.
Offering
- Filed: 2020-03-16
- Form: D
- Accession: 0001806781-20-000001
- Industry: Investing
- Exemptions: 06b
- Total offering: $150K
- Amount sold: $142K
- Remaining: $8K
- Minimum investment: $5K
- Investors: 14
- Date of first sale: 2020-03-12
- Security types: fund interests
- Revenue range: Not Applicable
- SEC file number: 021-362929
Issuer
- Name: Bioverge Funds, Excision Bio I, LLC
- CIK: 0001806781
- Entity type: Limited Liability Company
- Jurisdiction: IDAHO
- Incorporated: 2020
- Address: 575 E PARKCENTER BLVD #150, BOISE, ID, 83706
- Phone: 2086961262
Officers, directors & promoters (1)
| Name | Role | Location |
|---|
| Neil Bioverge Funds Management, LLC - Littman | Executive Officer | San Francisco, CA |
More